transparent gif
ImmuneSupport.com Home  
Abstract:
Chronic fatigue syndrome: new evidence for a central fatigue disorder
Fibromyalgia & Chronic Fatigue Syndrome Home Page Fibromyalgia & Chronic Fatigue Syndrome Library Fibromyalgia & Chronic Fatigue Syndrome Treatment and Research Email bulletins Fibromyalgia & Chronic Fatigue Syndrome Products Fibromyalgia & Chronic Fatigue Syndrome Community Area Fibromyalgia & Chronic Fatigue Syndrome About Us transparent gif transparent gif
transparent gif
Health Watch Newsletter background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
Home
Fibromyalgia Resources

Chronic Fatigue Syndrome Resources

E-mail Bulletin
Store
Community
About Us

Your Support Funds Research & Advocacy
HealthWatch Summer 2003
Abstract: Chronic fatigue syndrome: new evidence for a central fatigue disorder

ImmuneSupport.com

04-25-2003

Advertisement
Clin Sci (Lond) 2003 Apr 23; [epub ahead of print]

Georgiades E, Behan WM, Kilduff LP, Hadjicharalambous M, Mackie EE, Wilson J, Ward SA, Pitsiladis YP.

Considerable evidence points towards a prominent role for central neural (CNS) mechanisms in the pathogenesis of chronic fatigue syndrome (CFS), a disorder characterised chiefly by persistent, often debilitating, fatigue.

We wished to characterise circulating profiles of putative amino acid modulators of CNS serotoninergic and dopaminergic function in CFS patients at rest, during symptom-limited exercise and subsequent recovery. Twelve CFS patients and eleven age- and sex-matched sedentary controls, with similar physical activity histories, underwent ramp-incremental exercise to the limit of tolerance.

Plasma amino acid concentrations, oxygen uptake (Vo 2) and ratings of perceived exertion (RPE) were measured at rest, during exercise and recovery. Peak oxygen uptake (Vo 2peak) was significantly lower in the CFS patients, compared to controls. RPE in the patients was higher at all measured time points, including rest, relative to controls. Levels of free tryptophan [free Trp];the rate-limiting serotoninergic precursor, were significantly higher in CFS patients at exhaustion and recovery, whereas concentrations of branched-chain and large-neutral amino acids (BCAA and LNAA, respectively) were lower in patients at exhaustion and, for [LNAA], also during recovery.

Consequently, the [free Trp] : [BCAA] and [free Trp] : [LNAA] ratios were significantly higher in CFS patients, except at rest. On the other hand, levels of tyrosine, the rate-limiting dopaminergic precursor, were significantly lower at all time points in the patients. The significant differences observed in a number of key putative CNS serotoninergic and dopaminergic modulators, coupled with the exacerbated effort perception, provide further evidence for a potentially significant role of CNS mechanisms in CFS pathogenesis.

PMID: 12708966 [PubMed - as supplied by publisher]

  Newsletter SignUp Discuss (0 comments) Email Article Print Page

Every purchase funds research, donations and the community resources provided within our website.

Expected First Ship Date 06/02/2008
Pro-C Complex™

Expected First Ship Date 06/02/2008
Pro-C Complex™

Designed to increase symptom control over freezing, cramping and/or tremors
Parkinson's Disease CD From Health Journeys

Promote comfort, hope and energy
Multiple Sclerosis CD From Health Journeys

A powerful new approach to pain management
Ease Pain CD From Health Journeys

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community


ProHealth's ImmuneSupport.com- The World's Largest Fibromyalgia & Chronic Fatigue Syndrome Website!
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Careers, Contact us, Privacy, 30-day Money Back Guarantee